Geriatric Oncology Care in Brazil: Remote Geriatric Assessment-Driven Interventions With Supportive Care
NCT07084454 · Status: ENROLLING_BY_INVITATION · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 350
Last updated 2025-07-24
Summary
The goal of this clinical trial is to determine whether a telehealth-delivered, geriatric assessment-guided supportive care program (GAIN-S) can improve health outcomes in older adults (age 65 and above) with solid tumors who are starting a new cancer treatment in Brazil. The main questions it aims to answer are:
* Does GAIN-S improve physical function, as measured by activities of daily living (ADL), after three months?
* Does GAIN-S reduce symptoms of depression and improve quality of life after three months?
Researchers will compare patients receiving the GAIN-S intervention to those receiving standard care to see if the intervention leads to better physical function, fewer symptoms of depression, and improved quality of life.
Participants will:
* Complete a geriatric assessment (CARG-GA) before and after treatment.
* Be randomized to either standard care or the GAIN-S intervention.
* If assigned to GAIN-S, receive tailored supportive care via telehealth, which may include consultations with a psychologist, psychiatrist, nutritionist, geriatrician, exercise physiologist, or other specialists based on their needs.
Conditions
- Geriatric Assessment
- Geriatric Oncology
- Quality of Life
- Functional Decline
- Depression
- Aging
- Supportive Care in Cancer
- Activities of Daily Living
Interventions
- OTHER
-
GAIN-S Multidisciplinary Telehealth Intervention
This intervention delivers a comprehensive geriatric assessment (GA) via telehealth to older adults with cancer. Based on the GA results, a multidisciplinary team including oncologists, geriatricians, psychiatrists, psychologists, nutritionists, and certified fitness trainers provide personalized supportive care recommendations and consultations remotely. The goal is to improve physical function, reduce depressive symptoms, and enhance quality of life during cancer treatment.
- OTHER
-
Standard Oncology Care
Participants receive the usual oncology care provided by their treating physicians without a structured geriatric assessment-driven intervention. Geriatric assessment results are shared with the treating oncologist, who may refer patients to supportive care services based on clinical judgment. No coordinated multidisciplinary telehealth intervention is provided.
Sponsors & Collaborators
-
City of Hope Comprehensive Cancer Center
collaborator OTHER -
Cristiane Decat Bergerot, PhD
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-06
- Primary Completion
- 2028-11-30
- Completion
- 2028-11-30
Countries
- Brazil
Study Locations
More Related Trials
-
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer
NCT02573506 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients
NCT06082570 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
NCT06121505 ·Status: RECRUITING ·Phase: PHASE2
-
Prediction of Chemotherapy Toxicity and Survival in Elderly Cancer Patients by CARG Score
NCT05432726 ·Status: UNKNOWN
-
A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
NCT06898255 ·Status: RECRUITING ·Phase: PHASE1
-
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
NCT06265025 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT06092957 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921 ·Status: RECRUITING ·Phase: PHASE1
-
Observational Study of Survival Outcomes of Stage IV Cancer Patients
NCT01843985 ·Status: UNKNOWN
-
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
NCT06112041 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC
NCT02990780 ·Status: UNKNOWN ·Phase: PHASE3
-
Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer
NCT05557552 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC
NCT07052669 ·Status: RECRUITING ·Phase: PHASE3
-
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
NCT04767009 ·Status: RECRUITING ·Phase: PHASE2
-
Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC)
NCT07076693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
NCT05975307 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
NCT04952597 ·Status: COMPLETED ·Phase: PHASE2
-
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
NCT06611137 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)
NCT01201044 ·Status: UNKNOWN ·Phase: NA
-
High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer
NCT03598517 ·Status: UNKNOWN ·Phase: NA
-
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
NCT07242417 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer
NCT02675088 ·Status: UNKNOWN ·Phase: NA
-
Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma
NCT05760053 ·Status: RECRUITING ·Phase: PHASE2
-
Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
NCT07086456 ·Status: RECRUITING ·Phase: PHASE2
-
Cryotherapy Combine Icotinib for Advanced NSCLC Treatment
NCT02744664 ·Status: COMPLETED ·Phase: PHASE4